CFDE Data Portal | Search PHACTR2P1

	Label	Description
	PHACTR2P1 Gene (Entity type)	ENSG00000270300 - phosphatase and actin regulator 2 pseudogene 1
	GSE169617 azacitidine 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 10 v 15 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE173483 nutlin-3 U2OS 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE193838 catechin 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE193838 catechin 0 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE133447 GSE133448 MED25 ETV4 knockdown UFERSA-PC3 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE193838 catechin 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE119345 bexarotene T cell 2 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	RPS6KL1 IDG kinase ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG

PHACTR2P1

ENSG00000270300 - phosphatase and actin regulator 2 pseudogene 1

GSE169617 azacitidine 1 v 2 human up

A Gene Set from LINCS

GSE252944 AKT inhibition 10 v 15 human up

A Gene Set from LINCS

GSE173483 nutlin-3 U2OS 1 v 0 human dn

A Gene Set from LINCS

GSE193838 catechin 0 v 2 human dn

A Gene Set from LINCS

GSE193838 catechin 0 v 4 human dn

A Gene Set from LINCS

GSE133447 GSE133448 MED25 ETV4 knockdown UFERSA-PC3 2 v 1 human dn

A Gene Set from LINCS

GSE193838 catechin 0 v 1 human dn

A Gene Set from LINCS

GSE119345 bexarotene T cell 2 v 4 human dn

A Gene Set from LINCS

RPS6KL1 IDG kinase ARCHS4 coexpression

A Gene Set from IDG

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.